MSB 0.43% $1.16 mesoblast limited

Ann: FDA Accepts BLA for RYONCIL and Agrees to Priority Review, page-127

  1. 12,411 Posts.
    lightbulb Created with Sketch. 3370
    Assuming that rem-L covid-19 ARDS treatment works, So, how will this play out:
    1. Ryoncil will be approved first, before rem-L for covid-19 ARDS; or
    2. Rem-L for covid-19 ARDS will be approved first?

    A good problem to have, but I'm interested on how people view this possible scenario?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.16
Change
0.005(0.43%)
Mkt cap ! $1.318B
Open High Low Value Volume
$1.15 $1.17 $1.13 $3.743M 3.261M

Buyers (Bids)

No. Vol. Price($)
4 78561 $1.15
 

Sellers (Offers)

Price($) Vol. No.
$1.16 114667 4
View Market Depth
Last trade - 16.10pm 22/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.